Insulin glargine biosimilar (LG Life Sciences)

甘精胰岛素生物类似药 (LG Life Sciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin glargine biosimilar (LG Life Sciences)
Drug Alias Name甘精胰岛素生物仿制药 (LG Life Sciences)Basugine
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeA10AE04
Related LinksN/A